Esterase responsive release of anti-cancer agents from conjugated lipid nanocarrier and the regulatory considerations
{{output}}
The release of active agents in tumors rather than normal tissues, limits systemic exposure and toxicities. Targeting over-expressed esterase enzyme in the tumor microenvironment can selectively release immune-active agents like Programmed Death-1 (PD-1) and P... ...
